Medication Monitor

Generic Name (Trade Name—Company)
October 25, 2011


(No trade name—Multiple manufacturers)
First generic versions of atypical antipsychotic approved


Treatment of schizophrenia and bipolar disorder

The first generic versions of olanzapine tablets and orally disintegrating tablets have been approved, according to a FDA news release. The oral tablets will be manufactured by Dr. Reddy’s Laboratories and Teva Pharmaceuticals, and the orally disintegrating tablets will be manufactured by Apotex, Dr. Reddy’s Laboratories, and Par Pharmaceuticals.